-
1
-
-
77951576906
-
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C
-
DITTO-HCV NORDynamIC Study Groups.
-
References Askarieh G, Alsiö A, Pugnale P, Negro F, Ferrari C, Neumann AU, Pawlotsky JM, Schalm SW, Zeuzem S, Norkrans G, Westin J, Söderholm J, Hellstrand K, Lagging M; DITTO-HCV and NORDynamIC Study Groups. 2010. Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology. 51(5):1523-1530.
-
(2010)
Hepatology.
, vol.51
, Issue.5
, pp. 1523-1530
-
-
References Askarieh, G.1
Alsiö, A.2
Pugnale, P.3
Negro, F.4
Ferrari, C.5
Neumann, A.U.6
Pawlotsky, J.M.7
Schalm, S.W.8
Zeuzem, S.9
Norkrans, G.10
Westin, J.11
Söderholm, J.12
Hellstrand, K.13
Lagging, M.14
-
2
-
-
23744481169
-
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
-
DOI 10.1182/blood-2005-01-0126
-
Butera D, Marukian S, Iwamaye AE, Hembrador E, Chambers TJ, Di Bisceglie AM, Charles ED, Talal AH, Jacobson IM, Rice CM, Dustin LB. 2005. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood 106(4):1175-1182. (Pubitemid 41129575)
-
(2005)
Blood
, vol.106
, Issue.4
, pp. 1175-1182
-
-
Butera, D.1
Marukian, S.2
Iwamaye, A.E.3
Hembrador, E.4
Chambers, T.J.5
Di Bisceglie, A.M.6
Charles, E.D.7
Talal, A.H.8
Jacobson, I.M.9
Rice, C.M.10
Dustin, L.B.11
-
3
-
-
78650962504
-
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
-
Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A, Mallet V, Mottez E, Mapes J, Fontanet A, Pol S, Albert ML. 2011. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest 121(1):308-317.
-
(2011)
J Clin Invest
, vol.121
, Issue.1
, pp. 308-317
-
-
Casrouge, A.1
Decalf, J.2
Ahloulay, M.3
Lababidi, C.4
Mansour, H.5
Vallet-Pichard, A.6
Mallet, V.7
Mottez, E.8
Mapes, J.9
Fontanet, A.10
Pol, S.11
Albert, M.L.12
-
4
-
-
32144454172
-
Mechanisms of disease: The many roles of chemokines and chemokine receptors in inflammation
-
DOI 10.1056/NEJMra052723
-
Charo IF, Ransohoff RM. 2006. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354(6):610-621. (Pubitemid 43209108)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.6
, pp. 610-621
-
-
Charo, I.F.1
Ransohoff, R.M.2
-
5
-
-
33144462713
-
Association of pretreatment serum interferon γ inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C
-
DOI 10.1136/gut.2005.074062
-
Diago M, Castellano G, García-Samaniego J, Pérez C, Fernández I, Romero M, Iacono OL, García-Monzón C. 2006. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 55(3):374-379. (Pubitemid 43268277)
-
(2006)
Gut
, vol.55
, Issue.3
, pp. 374-379
-
-
Diago, M.1
Castellano, G.2
Garcia-Samaniego, J.3
Perez, C.4
Fernandez, I.5
Romero, M.6
Iacono, O.L.7
Garcia-Monzon, C.8
-
6
-
-
64749091883
-
New insights into the immunopathogenesis of chronic hepatitis C
-
Diepolder HM. 2009. New insights into the immunopathogenesis of chronic hepatitis C. Antiviral Res 82(3):103-109.
-
(2009)
Antiviral Res
, vol.82
, Issue.3
, pp. 103-109
-
-
Diepolder, H.M.1
-
7
-
-
79955018861
-
Chronic viral hepatitis: Epidemiology, molecular biology, and antiviral therapy
-
Gonzalez SA, Keeffe EB. 2011. Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy. Front Biosci 16:225-250.
-
(2011)
Front Biosci
, vol.16
, pp. 225-250
-
-
Gonzalez, S.A.1
Keeffe, E.B.2
-
8
-
-
61949194003
-
Chemokines in the immunopathogenesis of hepatitis C infection
-
Heydtmann M, Adams DH. 2009. Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology 49(2): 676-688.
-
(2009)
Hepatology
, vol.49
, Issue.2
, pp. 676-688
-
-
Heydtmann, M.1
Adams, D.H.2
-
9
-
-
57449102983
-
Hepatitis C virus (HCV): A review of immunological aspects
-
Irshad M, Khushboo I, Singh S, Singh S. 2008. Hepatitis C virus (HCV): A review of immunological aspects. Int Rev Immunol 27(6):497-517.
-
(2008)
Int Rev Immunol
, vol.27
, Issue.6
, pp. 497-517
-
-
Irshad, M.1
Khushboo, I.2
Singh, S.3
Singh, S.4
-
10
-
-
73949109333
-
Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution
-
Kasprowicz V, Kang YH, Lucas M, Schulze zur Wiesch J, Kuntzen T, Fleming V, Nolan BE, Longworth S, Berical A, Bengsch B, Thimme R, Lewis-Ximenez L, Allen TM, Kim AY, Klenerman P, Lauer GM. 2010. Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution. J Virol 84(3):1656-1663.
-
(2010)
J Virol
, vol.84
, Issue.3
, pp. 1656-1663
-
-
Kasprowicz, V.1
Kang, Y.H.2
Lucas, M.3
Schulze Zur Wiesch, J.4
Kuntzen, T.5
Fleming, V.6
Nolan, B.E.7
Longworth, S.8
Berical, A.9
Bengsch, B.10
Thimme, R.11
Lewis-Ximenez, L.12
Allen, T.M.13
Kim, A.Y.14
Klenerman, P.15
Lauer, G.M.16
-
11
-
-
33845662689
-
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
-
DOI 10.1002/hep.21407
-
Lagging M, Romero AI, Westin J, Norkrans G, Dhillon AP, Pawlotsky J-M, Zeuzem S, von Wagner M, Negro F, Schalm SW, Haagmans BL. Ferrari C, Missale G, Neumann AU, Verheij-Hart E, Hellstrand K. 2006. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 44(6):1617-1625. (Pubitemid 44953667)
-
(2006)
Hepatology
, vol.44
, Issue.6
, pp. 1617-1625
-
-
Lagging, M.1
Romero, A.I.2
Westin, J.3
Norkrans, G.4
Dhillon, A.P.5
Pawlotsky, J.-M.6
Zeuzem, S.7
Von Wagner, M.8
Negro, F.9
Schalm, S.W.10
Haagmans, B.L.11
Ferrari, C.12
Missale, G.13
Neumann, A.U.14
Verheij-Hart, E.15
Hellstrand, K.16
-
12
-
-
63449102214
-
Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection
-
Larrubia JR, Benito-Martínez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. 2008. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol 14(47):7149-7159.
-
(2008)
World J Gastroenterol
, vol.14
, Issue.47
, pp. 7149-7159
-
-
Larrubia, J.R.1
Benito-Martínez, S.2
Calvino, M.3
Sanz-De-Villalobos, E.4
Parra-Cid, T.5
-
13
-
-
77954799159
-
Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus
-
Lee S, Varano J, Flexman JP, Cheng W, Watson MW, Rossi E, Adams LA, Bulsara M, Price P. 2010. Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus. Dis Markers 28(5):273-280.
-
(2010)
Dis Markers
, vol.28
, Issue.5
, pp. 273-280
-
-
Lee, S.1
Varano, J.2
Flexman, J.P.3
Cheng, W.4
Watson, M.W.5
Rossi, E.6
Adams, L.A.7
Bulsara, M.8
Price, P.9
-
14
-
-
46249090636
-
Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection
-
DOI 10.1002/hep.22242
-
Neumann-Haefelin C, Timm J, Spangenberg HC, Wischniowski N, Nazarova N, Kersting N, Roggendorf M, Allen TM, Blum HE, Thimme R. 2008. Virological and immunological determinants of intrahepatic virus-specific CD8 + T-cell failure in chronic hepatitis C virus infection. Hepatology 47(6):1824-1836. (Pubitemid 351945550)
-
(2008)
Hepatology
, vol.47
, Issue.6
, pp. 1824-1836
-
-
Neumann-Haefelin, C.1
Timm, J.2
Spangenberg, H.C.3
Wischniowski, N.4
Nazarova, N.5
Kersting, N.6
Roggendorf, M.7
Allen, T.M.8
Blum, H.E.9
Thimme, R.10
-
15
-
-
58149493049
-
IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or nonresponse in HIV-HCV coinfection
-
Reiberger T, Aberle JH, Kundi M, Kohrgruber N, Rieger A, Gangl A, Holzmann H, Peck-Radosavljevic M. 2008. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or nonresponse in HIV-HCV coinfection. Antivir Ther 13(8):969-976.
-
(2008)
Antivir Ther
, vol.13
, Issue.8
, pp. 969-976
-
-
Reiberger, T.1
Aberle, J.H.2
Kundi, M.3
Kohrgruber, N.4
Rieger, A.5
Gangl, A.6
Holzmann, H.7
Peck-Radosavljevic, M.8
-
16
-
-
33749017951
-
Interferon (IFN)-γ-inducible protein-10: Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-α2a and ribavirin for chronic hepatitis C virus infection
-
DOI 10.1086/507307
-
Romero AI, Lagging M, Westin J, Dhillon AP, Dustin LB, Pawlotsky JM, Neumann AU, Ferrari C, Missale G, Haagmans BL, Schalm SW, Zeuzem S, Negro F, Verheij-Hart E, Hellstrand K; DITTO-HCV Study Group. 2006. Interferon (IFN)-gammainducible protein-10: Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis 194(7):895-903. (Pubitemid 44454074)
-
(2006)
Journal of Infectious Diseases
, vol.194
, Issue.7
, pp. 895-903
-
-
Romero, A.I.1
Lagging, M.2
Westin, J.3
Dhillon, A.P.4
Dustin, L.B.5
Pawlotsky, J.-M.6
Neumann, A.U.7
Ferrari, C.8
Missale, G.9
Haagmans, B.L.10
Schalm, S.W.11
Zeuzem, S.12
Negro, F.13
Verheij-Hart, E.14
Hellstrand, K.15
-
17
-
-
77953079035
-
Plasma interferon-gammainducible protein-10 can predict virologic response to hepatitis C virus therapy in HIV/HCV-coinfected patients with HCV genotype 1
-
Vargas A, Berenguer J, Ryan P, Catalán P, López JC, Cosín J, Miralles P, Resino S. 2010. Plasma interferon-gammainducible protein-10 can predict virologic response to hepatitis C virus therapy in HIV/HCV-coinfected patients with HCV genotype 1. J Acquir Immune Defic Syndr 54(2):219-220.
-
(2010)
J Acquir Immune Defic Syndr
, vol.54
, Issue.2
, pp. 219-220
-
-
Vargas, A.1
Berenguer, J.2
Ryan, P.3
Catalán, P.4
López, J.C.5
Cosín, J.6
Miralles, P.7
Resino, S.8
-
18
-
-
72849128563
-
Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection
-
Zeremski M, Dimova R, Brown Q, Jacobson IM, Markatou M, Talal AH. 2009. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection. J Infect Dis 200(11):1774-1780.
-
(2009)
J Infect Dis
, vol.200
, Issue.11
, pp. 1774-1780
-
-
Zeremski, M.1
Dimova, R.2
Brown, Q.3
Jacobson, I.M.4
Markatou, M.5
Talal, A.H.6
-
19
-
-
80052247715
-
CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C
-
Zeremski M, Dimova R, Astemborski J, Thomas DL, Talal AH. 2011. CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C. J Infect Dis 204(6):832-836.
-
(2011)
J Infect Dis
, vol.204
, Issue.6
, pp. 832-836
-
-
Zeremski, M.1
Dimova, R.2
Astemborski, J.3
Thomas, D.L.4
Talal, A.H.5
|